Palisade Bio, Inc.
PALI
$0.6902
-$0.0638-8.46%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.43% | 2.57% | -17.38% | -7.79% | -5.43% |
| Total Depreciation and Amortization | 0.00% | -25.00% | -25.00% | -50.00% | -40.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -60.43% | -4.53% | 11.53% | 32.70% | 1,161.00% |
| Change in Net Operating Assets | 104.01% | -46.61% | 247.75% | -7.05% | -35.09% |
| Cash from Operations | 20.05% | -5.18% | -9.52% | -7.40% | -0.13% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 15.33% | 24.51% | -8.95% | 33.27% | 38.47% |
| Issuance of Common Stock | -46.28% | -13.40% | -10.19% | -54.81% | -67.37% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 54.02% | -47.81% | -48.95% | 1.39% | 31.56% |
| Cash from Financing | -47.02% | -16.76% | -14.34% | -59.44% | -70.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.54% | -100.20% | -5,428.57% | -648.00% | -144.21% |